Predictive clinical parameters and glycemic efficacy of vildagliptin treatment in korean subjects with type 2 diabetes.

about

The efficacy of vildagliptin in korean patients with type 2 diabetes

P2860

Q38452916-D5F06738-11C6-4DE8-AB06-E09AA442CDE9

P2860

Predictive clinical parameters and glycemic efficacy of vildagliptin treatment in korean subjects with type 2 diabetes.

Item

http://www.wikidata.org/entity/Q36628919

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Predictive clinical parameters ...... subjects with type 2 diabetes.

@ast

Predictive clinical parameters ...... subjects with type 2 diabetes.

@en

type

Item

label

Predictive clinical parameters ...... subjects with type 2 diabetes.

@ast

Predictive clinical parameters ...... subjects with type 2 diabetes.

@en

prefLabel

Predictive clinical parameters ...... subjects with type 2 diabetes.

@ast

Predictive clinical parameters ...... subjects with type 2 diabetes.

@en

P1476

Predictive clinical parameters ...... subjects with type 2 diabetes.

@en

P2093

Bong-Yun Cha

http://www.w3.org/2001/XMLSchema#string

Ho-Young Son

http://www.w3.org/2001/XMLSchema#string

Hun-Sung Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Hyoung Cho

http://www.w3.org/2001/XMLSchema#string

Jeong-Ah Shin

http://www.w3.org/2001/XMLSchema#string

Jin-Sun Chang

http://www.w3.org/2001/XMLSchema#string

Juyoung Shin

http://www.w3.org/2001/XMLSchema#string

Kun-Ho Yoon

http://www.w3.org/2001/XMLSchema#string

Kyung-Hee Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes.

Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study.

Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients.

The role of GLP-1 in the life and death of pancreatic beta cells.

Impact of insulin resistance, body mass index, disease duration, and duration of metformin use on the efficacy of vildagliptin.

The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.

Incretin therapies in the management of patients with type 2 diabetes mellitus and renal impairment.

Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus.

P304

72-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4093/DMJ.2013.37.1.72

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235729446

http://www.w3.org/2001/XMLSchema#string

P698

23439802

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3579155

http://www.w3.org/2001/XMLSchema#string

Predictive clinical parameters and glycemic efficacy of vildagliptin treatment in korean subjects with type 2 diabetes.

about

P2860

P2860

Predictive clinical parameters and glycemic efficacy of vildagliptin treatment in korean subjects with type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932